Updated Jul 16, 2026
Upadhyay Suketu has filed 3 SEC Form 4 filings across 2 companies in the last 90 days.

Suketu Upadhyay has held significant roles in the financial leadership of major companies, including serving as Executive Vice President and Chief Financial Officer at Zimmer Biomet Holdings, Inc. He has also been involved with Vertex Pharmaceuticals. His experience spans across financial management and corporate governance in the healthcare sector.
| Role | EVP & Chief Financial Officer |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-06 | INCY | INCYTE CORP | A — Grant or award | 26.3K | $0.00 | |
| 2026-05-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | D — Derivative transaction | 796 | — | |
| 2026-03-10 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | F — Tax withholding / forfeiture | 2.0K | $92.54 | $188K |
| 2026-03-10 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | M — Option exercise | 4.6K | $0.00 | |
| 2026-03-10 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | F — Tax withholding / forfeiture | 4.5K | $92.54 | $421K |
| 2026-03-10 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | M — Option exercise | 10.2K | $0.00 | |
| 2026-02-27 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | F — Tax withholding / forfeiture | 2.8K | $99.51 | $282K |
| 2026-02-27 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | M — Option exercise | 6.4K | $0.00 | |
| 2026-02-25 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | F — Tax withholding / forfeiture | 2.4K | $98.62 | $241K |
| 2026-02-25 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | M — Option exercise | 5.4K | $0.00 | |
| 2024-11-12 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | F — Tax withholding / forfeiture | 7.1K | $108.48 | $770K |
| 2024-11-12 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | M — Option exercise | 15.9K | $0.00 |
Suketu Upadhyay has held significant roles in the financial leadership of major companies, including serving as Executive Vice President and Chief Financial Officer at Zimmer Biomet Holdings, Inc. He has also been involved with Vertex Pharmaceuticals. His experience spans across financial management and corporate governance in the healthcare sector.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Upadhyay Suketu profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.